Select Medical (SEM) Expected to Announce Earnings on Thursday

Select Medical (NYSE:SEM) is expected to be posting its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect Select Medical to post earnings of $0.17 per share and revenue of $1.3298 billion for the quarter. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS.Investors are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Friday, October 31, 2025 at 9:00 AM ET.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.04. The business had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.35 billion. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.60 EPS. On average, analysts expect Select Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Select Medical Stock Performance

Select Medical stock opened at $14.21 on Tuesday. The stock’s 50 day simple moving average is $13.08 and its two-hundred day simple moving average is $14.26. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.15 and a current ratio of 1.15. The stock has a market cap of $1.76 billion, a price-to-earnings ratio of 13.40, a PEG ratio of 0.58 and a beta of 1.28. Select Medical has a fifty-two week low of $11.65 and a fifty-two week high of $40.98.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th were given a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Wednesday, August 13th. Select Medical’s payout ratio is currently 23.58%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in SEM. Canada Pension Plan Investment Board bought a new position in shares of Select Medical during the 2nd quarter valued at about $168,000. Tower Research Capital LLC TRC boosted its holdings in shares of Select Medical by 282.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 11,639 shares of the health services provider’s stock valued at $177,000 after purchasing an additional 8,596 shares during the last quarter. Orion Porfolio Solutions LLC boosted its holdings in shares of Select Medical by 22.6% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 12,823 shares of the health services provider’s stock valued at $195,000 after purchasing an additional 2,368 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in shares of Select Medical during the 1st quarter valued at about $220,000. Finally, Oxford Asset Management LLP boosted its holdings in shares of Select Medical by 18.6% during the 2nd quarter. Oxford Asset Management LLP now owns 28,992 shares of the health services provider’s stock valued at $440,000 after purchasing an additional 4,544 shares during the last quarter. Institutional investors own 89.48% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on SEM shares. Benchmark reissued a “buy” rating on shares of Select Medical in a research report on Monday. Bank of America decreased their target price on shares of Select Medical from $18.00 to $15.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. UBS Group reiterated a “neutral” rating and set a $14.00 target price (down from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Royal Bank Of Canada upped their price objective on Select Medical from $16.00 to $20.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Select Medical in a research note on Wednesday, October 8th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $19.40.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.